SCHEMBL7599310

SCHEMBL7599310

CC/C(Cc1ccccc1)=C(\c1ccccc1)c1ccc(NCCOC)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.44
HPGD P15428 2/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CYP19A1 P11511 1/20 0.40
RORC P51449 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HDAC3 O15379 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
NCOR2 Q9Y618 1/20 0.39
KCNH3 Q9ULD8 3/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ABCB11 O95342 1/20 0.38
CYP3A4 P08684 1/20 0.38
ADRA2B P18089 1/20 0.38
OPRD1 P41143 1/20 0.38
SCN5A Q14524 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598327 1.00 ESR1 (0.44) ESR1HPGDCA1CA2CYP19A1
SCHEMBL7600096 0.93 ESR1 (0.48) ESR1HPGDCA1CA2CYP19A1
SCHEMBL7600098 0.93 ESR1 (0.48) ESR1HPGDCA1CA2CYP19A1
SCHEMBL7600070 0.93 ESR1 (0.47) ESR1HPGDNPC1RAB9AKCNH3
SCHEMBL7600075 0.93 ESR1 (0.47) ESR1HPGDNPC1RAB9AKCNH3
SCHEMBL7600851 0.93 ESR1 (0.43) ESR1HPGDCA1CA2CYP19A1
SCHEMBL7597702 0.93 ESR1 (0.43) ESR1HPGDCA1CA2CYP19A1
SCHEMBL7602310 0.92 ESR1 (0.49) ESR1HPGDCYP19A1NPC1RAB9A
SCHEMBL7602307 0.92 ESR1 (0.49) ESR1HPGDCYP19A1NPC1RAB9A
SCHEMBL7599042 0.89 ESR1 (0.43) ESR1HPGDCA1CA2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020161007-A1 Non-steroidal modulators of estrogen receptors PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161007-A1 Non-steroidal modulators of estrogen receptors ESRRB, ESR2, ESRRG ESR1 6/4885HPGD 206/4885CA1 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.